-
EP2190465
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2190465
| EP2190465 - USE OF THE PEPTIDES ACTH 1-24 AND SYNAPTOBREVIN 73-79 AS A THERAPEUTIC AGENT [Right-click to bookmark this link] | |||
| Former [2010/22] | USE OF A PEPTIDE AS A THERAPEUTIC AGENT | ||
| [2011/41] | Status | The application is deemed to be withdrawn Status updated on 29.06.2012 Database last updated on 19.07.2024 | Most recent event Tooltip | 29.06.2012 | Application deemed to be withdrawn | published on 01.08.2012 [2012/31] | Applicant(s) | For all designated states Mondobiotech Laboratories AG Herrengasse 21 9490 Vaduz / LI | [2010/22] | Inventor(s) | 01 /
BEVEC, Dorian Kriegerstrasse 62 82110 Germering / DE | 02 /
CAVALLI, Fabio Via Pasquée 23 CH-6925 Gentilino / CH | 03 /
CAVALLI, Vera Via Pasquée 23 CH-6925 Gentilino / CH | 04 /
BACHER, Gerald Masurenweg 5 82110 Germering / DE | [2010/22] | Representative(s) | Arth, Hans-Lothar ABK Patent Attorneys Jasminweg 9 14052 Berlin / DE | [N/P] |
| Former [2010/22] | Arth, Hans-Lothar ABK Patent Attorneys Jasminweg 9 14052 Berlin / DE | Application number, filing date | 08802270.2 | 09.09.2008 | [2010/22] | WO2008EP07741 | Priority number, date | EP20070017762 | 11.09.2007 Original published format: EP 07017762 | [2010/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2009040032 | Date: | 02.04.2009 | Language: | EN | [2009/14] | Type: | A2 Application without search report | No.: | EP2190465 | Date: | 02.06.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.04.2009 takes the place of the publication of the European patent application. | [2010/22] | Search report(s) | International search report - published on: | EP | 22.05.2009 | Classification | IPC: | A61K38/35, A61K38/08, A61P11/00, A61P13/00, A61P17/00, A61P25/00 | [2011/41] | CPC: |
A61K38/085 (EP,KR,US);
A61K38/35 (EP,KR,US);
A61P1/00 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P13/00 (EP);
A61P13/12 (EP);
A61P17/00 (EP);
A61P19/00 (EP);
A61P25/00 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P27/16 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/02 (EP);
A61P3/04 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/06 (EP);
A61P31/18 (EP);
A61P31/20 (EP);
A61P35/00 (EP);
A61P35/04 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
Y02A50/30 (EP,US)
(-)
|
| Former IPC [2010/22] | A61K38/35, A61K38/17, A61P3/00, A61P9/00, A61P11/00, A61P25/28, A61P31/00, A61P35/00, A61P37/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/22] | Title | German: | VERWENDUNG DER PEPTIDE ACTH 1-24 UND SYNAPTOBREVIN 73-79 ALS THERAPEUTISCHES MITTEL | [2011/41] | English: | USE OF THE PEPTIDES ACTH 1-24 AND SYNAPTOBREVIN 73-79 AS A THERAPEUTIC AGENT | [2011/41] | French: | UTILISATION DES PEPTIDES ACTH 1-24 ET SYNAPTOBREVIN 73-79 EN TANT QU'AGENT THÉRAPEUTIQUES | [2011/41] |
| Former [2010/22] | VERWENDUNG EINES PEPTIDS ALS THERAPEUTISCHES MITTEL | ||
| Former [2010/22] | USE OF A PEPTIDE AS A THERAPEUTIC AGENT | ||
| Former [2010/22] | UTILISATION D'UN PEPTIDE EN TANT QU'AGENT THÉRAPEUTIQUE | Entry into regional phase | 09.03.2010 | National basic fee paid | 09.03.2010 | Designation fee(s) paid | 09.03.2010 | Examination fee paid | Examination procedure | 09.03.2010 | Amendment by applicant (claims and/or description) | 09.03.2010 | Examination requested [2010/22] | 05.11.2010 | Despatch of a communication from the examining division (Time limit: M06) | 26.04.2011 | Reply to a communication from the examining division | 20.07.2011 | Despatch of a communication from the examining division (Time limit: M04) | 24.07.2011 | Reply to a communication from the examining division | 29.09.2011 | Communication of intention to grant the patent | 10.02.2012 | Application deemed to be withdrawn, date of legal effect [2012/31] | 15.03.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2012/31] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 05.11.2010 | Fees paid | Renewal fee | 21.08.2010 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.09.2011 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2006052468 (UNIV DENVER [US], et al) [X] 1,6-15 * paragraphs [0137] , [0138]; claim 23 *; | [X]WO0122991 (BERG ANNA LENA [SE], et al) [X] 1,10,12 * page 2, paragraph 1 * * page 1, lines 22-26 * * page 3, paragraphs 1-5 *; | [X] - BAZZANI C ET AL, "ACTH-induced reversal of hemorrhagic shock: further studies on the mechanism of action.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (199401), Database accession no. NLM7761678, XP002516357 [X] 1,6,8-15 * abstract * | [ ] - RIVISTA EUROPEA PER LE SCIENZE MEDICHE E FARMACOLOGICHE = EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES = REVUE EUROPÉENNE POUR LES SCIENCES MÉDICALES ET PHARMACOLOGIQUES 1994 JAN-APR, (199401), vol. 16, no. 1-2, ISSN 0392-291X, pages 27 - 31 | [X] - ZWERMANN OLIVER ET AL, "ACTH 1-24 inhibits proliferation of adrenocortical tumors in vivo", EUROPEAN JOURNAL OF ENDOCRINOLOGY, (200509), vol. 153, no. 3, ISSN 0804-4643, pages 435 - 444, XP002516356 [X] 1,6,8-15 * abstract * DOI: http://dx.doi.org/10.1530/EJE.1.01983 | [X] - KUSSE M C ET AL, "The effect of non-depot ACTH-(1-24) on infantile spasms", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (1993), Database accession no. PREV199497092921, XP002516358 [X] 1,6,8-15 * abstract * | [ ] - DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, (1993), vol. 35, no. 12, ISSN 0012-1622, pages 1067 - 1073 | [X] - DELGADO RENE ET AL, "Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (199806), Database accession no. PREV199800319623, XP002516359 [X] 1,6,8-15 * abstract * | [ ] - JOURNAL OF LEUKOCYTE BIOLOGY, (199806), vol. 63, no. 6, ISSN 0741-5400, pages 740 - 745 | [X] - BEVILACQUA M ET AL, "The role of melanotropins in nerve regeneration and immune defenses", INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, BIOSCIENCE EDIPRINT INC., CAROUGE-GENEVA, CH, (19970101), vol. 13, no. 1-2, ISSN 0255-9625, pages 25 - 31, XP009111948 [X] 1,6,8-15 * abstract * | by applicant | WO9729782 | WO03043429 | US5962062 | WO0030461 | EP0527283 | EP0832565 |